Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors
Clinical trial NCT05231733 · WITHDRAWN
Trial details
- NCT number
- NCT05231733
- Sponsor
- SparX Biotech(Jiangsu) Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-01
- Primary completion
- 2024-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.